☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AstraZeneca’s Forxiga (dapagliflozin) Receives EU Approval for the treatment of Symptomatic Chronic Heart Failure
February 7, 2023
Dr. Philip M. Toleikis, President & CEO at Sernova Shares Insights on the Partnership with Evotec to Develop a ‘Functional Cure’ f...
February 7, 2023
Tonix Reports the First Patient Enrollment in the P-II Study (PREVENTION) of TNX-1900 for the Prevention of Migraine Headaches in...
February 7, 2023
Genentech Reports P-III Study (COMMODORE 2) Results of Crovalimab for Paroxysmal Nocturnal Hemoglobinuria
February 7, 2023
InnoCare Published P-II Study Results of Orelabrutinib in P-II Study for Cancers in American Journal of Hematology
February 7, 2023
Janssen Reports P-II Trial Results of Nipocalimab for the Treatment of Severe Hemolytic Disease
February 7, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions